Follow a botanical antimicrobial protocol optimized for Borrelia burgdorferi

A structured 28-day botanical antimicrobial ramp-up protocol combined with biofilm disruption, optimized for North American Lyme disease (B. burgdorferi sensu stricto). Herb selection and sequencing prioritize compounds with the strongest in vitro evidence against B. burgdorferi morphological forms, including the landmark Feng et al. (2020) study where Cryptolepis sanguinolenta was the only agent to achieve complete eradication of stationary-phase Borrelia.

Protocol Structure

Three tracks are introduced in sequence to minimize Herxheimer reactions and isolate tolerance issues:

Days	Track	Action	Details
1–3	Biofilm	Disruptors only	NAC + serrapeptase + nattokinase + stevia at half dose
4–6	Tier 1	+ Cryptolepis ½ dose	Strongest single-agent evidence — complete eradication
7–9	Tier 1	Cryptolepis → full	+ Black walnut ½ dose
10–12	Tier 1	Black walnut → full	Biofilm → full dose, + knotweed ½ dose
13–15	Tier 1	Knotweed → full	+ Cat's claw ½ dose
16–20	Tier 1	All Tier 1 at full dose	Settle into routine
21–28	Tier 2	+ Tier 2 herb	Full protocol by Day 28

Days 1–3: Biofilm Disruptors Only

Take on an empty stomach each morning. No antimicrobial herbs yet — give the disruptors a head start weakening the biofilm matrix.

• NAC 600 mg
• Serrapeptase 60,000 SPU (enteric-coated)
• Nattokinase 1,000 FU
• Stevia whole-leaf extract: 1 dropper in water
• Drink 3+ liters water daily throughout the entire protocol

Days 4–6: First Herb — Cryptolepis

Continue biofilm disruptors at half dose. Add:

• Cryptolepis tincture: ½ tsp (2.5 mL) with breakfast + ½ tsp with dinner

Cryptolepis leads because it has the strongest single-agent evidence against B. burgdorferi — the only compound (including antibiotics doxycycline and cefuroxime) to achieve complete eradication of stationary-phase Borrelia with no regrowth in subculture (Feng et al. 2020). Monitor for Herxheimer reaction (temporary worsening from bacterial die-off). This is expected and indicates activity.

Days 7–9: Cryptolepis Full + Black Walnut

• Cryptolepis: increase to 1 tsp (5 mL) 3x/day with meals
• Black walnut green hull tincture: ½ tsp 2x/day with meals

Days 10–12: Black Walnut Full + Biofilm Full + Japanese Knotweed

• Black walnut: increase to 1 tsp 3x/day with meals
• Biofilm disruptors to full dose: NAC 600 mg 2x/day, serrapeptase 120,000 SPU morning, nattokinase 2,000 FU morning, stevia 1–2 droppers 2x/day
• Japanese knotweed: 250 mg 2x/day with meals

Japanese knotweed was among the most potent botanicals against replicating B. burgdorferi (MIC = 0.03–0.06%) and showed significant activity against stationary-phase persisters at 1% concentration.

Days 13–15: Knotweed Full + Cat's Claw

• Japanese knotweed: increase to 500 mg 3x/day with meals
• Cat's claw: 250 mg 2x/day with meals

Cat's claw bark extracts demonstrated antimicrobial effects against several morphological forms of B. burgdorferi, with activity attributed to proanthocyanidins. Also provides immunomodulatory support.

Days 16–20: All Tier 1 at Full Dose

• Cat's claw: increase to 500 mg 3x/day
• All four Tier 1 herbs now at full dose. Settle into the routine.

Days 21–28: Add Tier 2 Herb

Choose one based on clinical picture:

• Chinese skullcap (baicalein) 500 mg — effective against all three morphological forms of B. burgdorferi (Goc et al. 2015); also inhibits COX-2/NF-κB inflammation
• Artemisia annua 500 mg — if Babesia co-infection suspected (night sweats, air hunger, temperature dysregulation); also showed persister activity in Feng et al.
• Allicin (stabilized garlic) 450 mg — disrupts biofilm quorum sensing; garlic essential oil sterilized stationary-phase Borrelia cultures at 0.05% concentration (Feng et al. 2017)

Start at half dose (1x/day) on Day 21, increase to full dose (2–3x/day) by Day 24. A second Tier 2 herb may be added at Day 27.

Full Daily Schedule (Day 28 Onward)

Time	Take
6:30 AM empty stomach	NAC 600 mg + serrapeptase 120K SPU + nattokinase 2K FU
7:00 AM breakfast	Cryptolepis 1 tsp + black walnut 1 tsp + knotweed 500 mg + cat's claw 500 mg + Tier 2 herb + stevia 1–2 droppers
12:00 PM lunch	Cryptolepis 1 tsp + black walnut 1 tsp + knotweed 500 mg + cat's claw 500 mg + Tier 2 herb
6:00 PM dinner	Cryptolepis 1 tsp + black walnut 1 tsp + knotweed 500 mg + cat's claw 500 mg + stevia 1–2 droppers
9:00 PM	NAC 600 mg

Monitoring Checkpoints

Week 8: Test CRP and compare to baseline. Review symptoms journal.

• CRP dropped more than 30%: continue protocol
• CRP dropped 10–30%: continue, retest at Week 12
• No change: continue to Week 12 before deciding

Week 12: Test CRP again. This is the key decision point.

• CRP dropping + symptoms improving: continue 3–6 more months
• CRP stable + mixed symptoms: continue 3 months, consider swapping Tier 2 herbs
• No CRP change + no improvement: protocol is not working — seek medical evaluation
• CRP rising + symptoms worse: stop all antimicrobials immediately and see a doctor

Tapering (After 6–9 Months of Response)

Drop herbs one at a time with 2-week observation gaps: Tier 2 herbs first, then cat's claw, black walnut, Japanese knotweed, and cryptolepis last (strongest standalone evidence). If symptoms return after dropping a herb, resume it for 2 more months before trying again. Continue biofilm disruptors for 4 weeks after the last herb is stopped. Test CRP at 2 weeks and 4 weeks after full stop.

Herxheimer Reaction Management

Worsening symptoms in weeks 1–3 indicates bacterial die-off and is expected. Manage with:

• Activated charcoal 500 mg taken 2+ hours away from all herbs (charcoal absorbs everything indiscriminately)
• Increase water to 4+ liters/day
• Temporarily halve herb doses for 2–3 days, then resume full dose
• Do not stop entirely unless symptoms are severe — stopping removes antimicrobial pressure and allows surviving bacteria to repopulate

Stop and seek medical help if: fever above 103°F / 39.4°C, difficulty breathing, severe chest pain, or symptoms worsen continuously beyond Week 3 with no improvement.

28-Day Shopping List

Recommended products selected for exact protocol match and lowest cost. Chinese skullcap is used as the Tier 2 example. Prices are per-unit costs from the product comparison pages and may vary by retailer and bottle size.

Ingredient	Recommended Product	28-Day Qty	Unit Cost	Est. Cost
NAC 600mg	NOW Foods	47 caps	$0.07/cap	$3.29
Serrapeptase 120K SPU	Doctor's Best (Serrateric)	28 caps	$0.20/cap	$5.60
Nattokinase 2K FU	Doctor's Best (K2-removed)	28 caps	$0.16/cap	$4.48
Stevia whole-leaf	NutraMedix (study product)	~2.2 oz	$17.48/oz	$38.46
Cryptolepis tincture	Woodland Essence	~11.7 oz	$12.50/oz	$146.25
Black walnut tincture	Herb Pharm (fresh green hull)	~10.1 oz	$15.89/oz	$160.49
Japanese knotweed	Supreme Nutrition (375mg whole herb)	54 caps	$0.60/cap	$32.40
Cat's claw 500mg	NOW Foods	42 caps	$0.09/cap	$3.78
Chinese skullcap 500mg	Nutricost Baikal Skullcap	13 caps	$0.09/cap	$1.17
Activated charcoal	NOW Foods (280mg)	~14 caps	$0.07/cap	$0.91
			Total	~$397

• NutraMedix Stevia is the specific product used in the Theophilus et al. (2015) biofilm study — chosen over the budget alternative Hawaii Pharm ($3.75/oz) because it is the only study-tested product
• Woodland Essence is the most cited cryptolepis brand in the Lyme botanical community — larger bottles (4 oz, 8 oz) offer significantly lower per-ounce pricing
• Supreme Nutrition Japanese Knotweed is 375 mg whole herb per capsule (not standardized resveratrol extract) — take 1 capsule per protocol dose
• Activated charcoal quantity assumes ~7 uses during Herxheimer management (as needed)
• NOW Foods, Doctor’s Best, NutraMedix, and Nutricost are all available on iHerb.com, reducing ordering to 4 locations (+ Woodland Essence direct, Herb Pharm, Supreme Nutrition direct)

Important Limitations

• All supporting research is in vitro (laboratory). No human clinical trials have been published for this protocol or any of these herbs as Borrelia treatments.
• One in-vivo human study (Diederich et al. 2024, 452 European Lyme patients) showed botanical antibiotics were as effective as conventional antibiotics in reducing disease activity measured by LTT, though this study used European patients with likely Eurasian species infections.
• NAC evidence against Borrelia biofilms specifically is extrapolated from its documented activity against biofilms of other bacterial species.
• This protocol does not replace conventional antibiotic treatment for confirmed acute Lyme disease or neuroborreliosis.
• Individual responses vary. What works in a test tube may not work identically in the body.

Research Basis

The herbs in this protocol were selected based on published laboratory research conducted on B. burgdorferi sensu stricto:

• Feng et al. (2020), Frontiers in Medicine — tested 12 botanical medicines against both growing and dormant (persister) forms of B. burgdorferi. Cryptolepis sanguinolenta was the only agent — including antibiotics doxycycline and cefuroxime — to achieve complete eradication of stationary-phase Borrelia with no regrowth in subculture. Japanese knotweed, black walnut, cat's claw, Artemisia annua, and Chinese skullcap also showed significant activity against persisters.
• Goc et al. (2015, 2016), Journal of Applied Microbiology / International Journal of Biological Sciences — tested phytochemicals against all three morphological forms (spirochetes, round bodies, biofilm) of B. burgdorferi. Baicalein from Chinese skullcap was effective against all three forms, reducing biofilms by 30–60%.
• Theophilus et al. (2015), European Journal of Microbiology and Immunology — whole-leaf Stevia rebaudiana extract reduced Borrelia biofilm by 40% on plastic and 34% on collagen surfaces, outperforming individual antibiotics and a triple-antibiotic combination.
• Feng et al. (2017), Frontiers in Medicine — garlic essential oil sterilized stationary-phase Borrelia cultures at 0.05% concentration, the most effective of 34 essential oils tested.